Endocrinology & metabolism
Hormones & metabolism clinical trials
Diabetes, obesity, thyroid, and other conditions of the body’s hormones and metabolism. We’re tracking 7,607 recruiting studies in this area right now.
By phase
- Not applicable5,335
- Phase 2607
- Phase 1557
- Phase 3417
- Phase 4318
- Phase 1/Phase 2288
- Phase 2/Phase 385
Top conditions
- Obesity619
- Ovarian Cancer336
- Pancreatic Cancer289
- Type 2 Diabetes276
- Diabetes192
- Diabetes Mellitus183
- Diabetes Mellitus, Type 2170
- Hypertension138
- Type 1 Diabetes130
- Metabolic Syndrome126
- Obesity & Overweight123
- Breast Cancer111
- Overweight106
- Cardiovascular Diseases105
- Amyotrophic Lateral Sclerosis102
- Colorectal Cancer92
- Pancreas Cancer90
- Endometrial Cancer87
Leading sponsors
- Mayo Clinic87
- Novo Nordisk A/S64
- University of Colorado, Denver53
- Assistance Publique - Hôpitaux de Paris52
- M.D. Anderson Cancer Center41
- Massachusetts General Hospital41
- Eli Lilly and Company40
- IRCCS Azienda Ospedaliero-Universitaria di Bologna40
- National Taiwan University Hospital40
- Cairo University38
Where studies are running
- California521
- Maryland180
- Alabama176
- Arizona170
- Florida166
- Texas158
- Massachusetts151
- New York142
- Colorado115
- Pennsylvania113
Recruiting studies7,607 total
- NCT06225882Recruiting
Follow-up study for patients with primary hyperoxaluria type 1 on Lumasiran
This study follows patients with primary hyperoxaluria type 1 who are being treated with Lumasiran. It aims to understand how well the treatment works over time.
BesançonAges birth–99 years - NCT06228677Recruiting
Catecholamine levels during adrenal artery embolization
This trial measures hormone levels in blood during a procedure to treat high blood pressure caused by an adrenal gland problem. It may help doctors understand how the body responds during treatment.
Chengdu, SichuanAges 18 years+ - NCT05904353Recruiting
Care coordination program after hip fracture and osteoporosis
This trial aims to improve how primary care and hospital care work together to treat osteoporosis after a hip fracture. It may help by making follow-up treatment plans and communication clearer after your hip injury.
Lørenskog, AkershusAges 75 years+ - NCT06229522Recruiting
Organoids to personalize ovarian cancer treatment
This study uses lab-grown tumor models (organoids) from your tissue or fluid sample to find the best treatment for your ovarian cancer.
Aviano, PordenoneAges 18 years+ - NCT06229340RecruitingPhase 2
Two drug combinations for advanced cancer with RAS mutations
This trial tests two different treatment combinations (leflunomide alone or with MEK inhibitor and hydroxychloroquine) in people with advanced cancer that has a RAS mutation and has not responded to at least two prior therapies.
Saint PetersburgAges 18–85 - NCT07853898Recruiting
Pistachio snack trial for young adults with overweight
This study looks at how eating pistachios affects blood sugar and appetite after meals in young adults with overweight or obesity. Participants will eat pistachio snacks or a refined-carb snack and have blood tests to compare the effects.
St Louis, MissouriAges 18–35 - NCT07869069Recruiting
Mobile heart health visits for remote communities
This study brings heart health checkups to Indigenous and remote communities using a mobile health unit. It aims to improve heart disease prevention and make healthcare more accessible.
Québec, QuebecAges 35–65 - NCT07865117Recruiting
Personalised nutrition app for teenagers with cancer
This study is developing a smartphone app that gives personal nutrition advice to teenagers going through cancer treatment. The goal is to help them eat better and feel better.
Leuven, Vlaams BrabantAges 12–18 - NCT07855939Recruiting
Iron absorption and loss in women over time
This study looks at how well women absorb iron and lose it over a long period. It compares normal-weight women with overweight or obese women who have low-level inflammation. The goal is to understand iron levels in the body, which could help improve iron recommendations.
Nakhon PathomAges 40–50 - NCT07870538RecruitingPhase 4
Matching weight-loss treatments to binge eating patterns
This study tests whether a medication called semaglutide, which is used for weight loss, works better for people who also have binge eating. It aims to find the best treatment based on brain and behavior differences.
LeuvenAges 18–65 - NCT07859787Recruiting
Blood test for early or late puberty
This study checks if a blood marker called INSL3 can help doctors tell when puberty is starting early or late. It may help diagnose conditions like central precocious puberty or delayed puberty more accurately.
BolognaAges birth–18 years - NCT07868601Recruiting
Lifestyle and metabolism study for overweight adults
This study looks at how different lifestyle factors and metabolism affect health in overweight adults. It may help researchers understand how to better tailor nutrition and lifestyle advice.
Potsdam, Potsdam-RehbrückeAges 40–75 - NCT05962892Recruiting
Study of thyroid cancer return risk after heat ablation
This study looks at what makes papillary thyroid cancer come back after a heat-based treatment called thermal ablation. It may help doctors better predict recurrence risk and guide follow-up after treatment.
BeijingAges 18 years+ - NCT06232122Recruiting
New PET scans to detect ovarian cancer recurrence
This study uses two types of PET/CT scans (68Ga-FAPI-46 and 18F-FDG) to look for any returning ovarian cancer. The goal is to find recurrence early so you and your doctor can plan the next steps.
Taoyuan CityAges 30–80 - NCT06178120Recruiting
Study of disease progression in women with X-linked adrenoleukodystrophy
This study follows women with a genetic condition called X-linked adrenoleukodystrophy (ALD) over time to see how the disease progresses. It includes annual check-ups and MRI scans of the brain and spinal cord to monitor changes.
ParisAges 18 years+ - NCT06236750Recruiting
Testing a human tissue wound covering for hard-to-heal ulcers
This study is testing a special wound covering made from donated human tissue (amnion/chorion membrane) to see if it helps heal stubborn diabetic foot ulcers or venous leg ulcers that haven't improved with standard care. The covering is placed on the wound to help it heal.
Kobe, HyōgoAges Any age - NCT04176523Recruiting
Study of long-term carglumic acid use in organic acidemia
This study looks at how people with organic acidemia (like MMA or PA) do over the long term while taking carglumic acid. The research may help improve long-term management and support for patients and caregivers.
BordeauxAges 6 months–99 years - NCT06234787Recruiting
Continuous glucose monitoring in ICU patients
This study looks at how well continuous glucose monitors (small sensors under the skin that track sugar levels) work in ICU patients who need insulin. If you are in the ICU, on insulin, and already have a sensor, you may be able to join.
MadridAges 18 years+ - NCT05753826RecruitingPhase 2
Study of two medicines for platinum-resistant ovarian cancer
This Phase 2 trial studies whether adding adebrelimab to fuzuloparib can help people with ovarian cancer that comes back quickly after platinum chemotherapy. It is aimed especially at tumors with a specific DNA-repair gene (HRR mutation).
FujianAges 18–70 - NCT03409003Recruiting
Carbaglu monitoring study for suspected NAGS deficiency
This study follows people who have (or might have) NAGS deficiency and who are taking Carbaglu to treat it. The goal is to better track safety and health outcomes over time.
Washington D.C., District of ColumbiaAges Any age - NCT04602325Recruiting
Blood and brain injury biomarker study for inherited metabolic disorders
This trial studies blood and other measurable signs (biomarkers) that may reflect brain injury after certain inherited metabolic conditions. Results may help doctors better detect and understand brain effects from these illnesses, especially episodes that affect the brain.
Washington D.C., District of ColumbiaAges 7–18 - NCT05963841Recruiting
Testing AI to improve parathyroid scan imaging
This study uses past and future parathyroid scan data to train and test an AI tool. The goal is to improve how the scans are interpreted using nuclear medicine imaging from a specific scanning process.
BesançonAges 18 years+ - NCT06245330RecruitingPhase 1/Phase 2
Study of AST-001 for advanced solid tumors
This trial is testing a new drug called AST-001 for people with advanced solid tumors (including pancreatic cancer) that have not responded to standard treatments. The study aims to find the right dose and see how well the drug works.
Changchun, JinlinAges 18–70 - NCT05983276RecruitingPhase 2
Combination therapy for drug-resistant ovarian cancer
This trial tests a new two-drug combination (decitabine and selinexor) given with standard chemotherapy to see if it can reverse drug resistance in ovarian cancer that has come back or worsened after treatment.
Maywood, IllinoisAges 18 years+
Common questions
- How many hormones & metabolism clinical trials are recruiting?
- Clin2 is tracking 7,607 recruiting endocrinology & metabolism studies from the U.S. registry right now, out of 11,814 we cover in this area in total.
- What does “Hormones & metabolism” cover here?
- Diabetes, obesity, thyroid, and other conditions of the body’s hormones and metabolism. We group each study into hormones & metabolism based on the conditions it studies, so you can scan the whole therapeutic area at once and drill into a specific condition.
- How do I find a hormones & metabolism trial near me?
- Use the search to filter hormones & metabolism studies by location and eligibility. Every Clin2 trial page explains the criteria in plain English and offers a short, optional pre-screen for a fit read — the study team makes the final decision.
Other specialties
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov; specialty groupings are derived from each study’s conditions. Talk with your doctor about whether a specific trial is right for you.